DRUG DISCOVERY OUTSOURCING MARKET ANALYSIS
Global Drug Discovery Outsourcing Market: Key Developments
In January 2022, Shanghai Fosun Pharmaceutical (Group) Co., Ltd. entered into a collaboration agreement with Insilico Medicine, an end-to-end artificial intelligence (AI)-driven drug discovery and development company to advance the discovery and development of drugs targeting a number of different targets globally through the use of AI technology.
In January 2022, Evotec partnered with Eli Lilly and Company for the drug discovery of metabolic diseases. Under the agreement, Evotec will identify potential drug candidates to treat diabetes and chronic kidney diseases from targets selected by either of the companies.
In September 2021, Eurofins and Liverpool ChiroChem Ltd. teamed up to offer improved chemical expertise by accessing Liverpool ChiroChem’s PROTAC linker molecules to augment the unified drug discovery platform, DiscoveryOne.
In July 2022, GenScript ProBio and DAAN Bio Therapeutics entered into a strategic cooperation regarding the development of innovative drug development and discovery.
Need a Custom Report?
We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports
Customize Now
Credibility and Certifications
9001:2015
27001:2022
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients
U.S.: 
U.K. : 
India :